Hershey profits from 'Ozempic breath' as mint sales rise

Hershey is seeing a boost in sales of its mints and gum, thanks to the growing popularity of weight-loss drugs like Ozempic. The company says the demand is linked to a side effect of these medications: a condition known as "Ozempic breath." GLP-1 drugs, such as Ozempic and Wegovy, help control appetite and reduce blood sugar. However, they also slow digestion, which can cause bad breath. This has created a new opportunity for Hershey's breath-freshening products. Even as users of these drugs cut down on snacks and candy, they are buying more mints and gum to combat the unpleasant taste. Hershey reported that this trend is driving recent sales growth in its gum and mint category. The shift highlights an unexpected effect of the weight-loss boom. While the drug reduces cravings for sugary treats, it is sparking a new need for breath fresheners. Hershey is capitalizing on this side effect, turning a medical downside into a business upside.